Imagine the Possibilities Together
The Xavier Artificial Intelligence Initiative includes the work Xavier Health is doing with FDA and industry, and combining those efforts with what healthcare providers need to advance diagnostic capabilities and patient health. The American Medical Association (AMA) is teaming with Xavier to ensure physicians are part of product development so the user interface is “simple, usable and beautiful.”
Through Xavier University, FDA officials and industry professionals are working collaboratively to advance the pharmaceutical and medical device industries by augmenting human decisions with artificial intelligence such that decisions are more informed. The use of artificial intelligence will move the industry from reactive to proactive, then from proactive to predictive, and finally from predictive to prescriptive such that actions are right-first-time. Through the Xavier Artificial Intelligence Initiative, the industry will increase patient safety by ensuring the consistency of product quality.
The Xavier Artificial Intelligence Initiative engages pharmaceutical and medical device professionals, FDA officials, major industry associations, and physicians/healthcare providers to identify ways to implement artificial intelligence across product development, quality operations, regulatory affairs and supply chain operations.
FDA/Industry Working Teams
Through the Xavier Artificial Intelligence Initiative, chartered working teams have been established during the face-to-face setting of the annual Xavier AI Summit. The teams that are currently formed are as follows, and are accepting new members: